Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas

Annals of Oncology

Volumn 20, Issue 8, 2009, Pages 1408-1413

  Hohaus, Stefan ^a   Giachelia, M ^a   Massini, G ^a   Mansueto, G ^a   Vannata, B ^a   Bozzoli, V ^a   Criscuolo, M ^a   D'Alo F ^a   Martini, M ^a   Larocca, L M ^a   Voso, M T ^a   Leone, G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Circulating DNA; Hodgkin's lymphoma; Non Hodgkin's lymphoma; Prognosis; Quantitative PCR

Indexed keywords

BETA GLOBIN; DNA; LACTATE DEHYDROGENASE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD LEVEL; CANCER GRADING; CANCER SURVIVAL; CELL FREE SYSTEM; CONTROLLED STUDY; FEMALE; FOLLICULAR LYMPHOMA; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; NODULAR SCLEROSIS HODGKIN LYMPHOMA; NONHODGKIN LYMPHOMA; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; BLOOD; GENETICS; MIDDLE AGED; PATHOLOGY; STATISTICAL MODEL;

ADULT; AGED; BETA-GLOBINS; DNA, NEOPLASM; FEMALE; HODGKIN DISEASE; HUMANS; LOGISTIC MODELS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; YOUNG ADULT;

EID: 69449105599     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp006     Document Type: Article

References (25)

1. Tsang JC, Lo YM. Circulating nucleic acids in plasma/serum. Pathology 2007; 39: 197-207.
2. Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer - a survey. Biochim Biophys Acta 2007; 1775: 181-232.
3. Vasioukhin V, Anker P, Maurice P et al. Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia. Br J Haematol 1994; 86: 774-779.
4. Rogers A, Joe Y, Manshouri T et al. Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasia. Blood 2004; 103: 2799-2801.
5. Jilani I, Estey E, Manshuri T et al. Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNA. Leukemia 2003; 17: 114-119.
6. Frickhofen N, Muü ller E, Sandherr M et al. Rearranged Ig heavy chain DNA is detectable in cell-free blood samples of patients with B-cell neoplasia. Blood 1997; 90: 4953-4960.
7. Deligezer U, Yaman F, Erten N, Dalay N. Frequent copresence of methylated DNA and fragmented nucleosomal DNA in plasma of lymphoma patients. Clin Chim Acta 2003; 335: 89-94.
8. Gocke CD, Kopreski MS, Benko FA et al. Serum BCL2/IGH DNA in follicular lymphoma patients: A minimal residual disease marker. Leuk Lymphoma 2000; 39: 165-172.
9. Kornacker M, Jox A, Vockerodt M et al. Detection of a Hodgkin/ Reed-Sternberg cell specific immunoglobulin gene rearrangement in the serum DNA of a patient with Hodgkin's disease. Br J Haematol 1999; 106: 528-531.
10. Sozzi G, Conte D, Leon M et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 2003; 21: 3902-3908.
11. Sozzi G, Conte D, Mariani L et al. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res 2001; 61: 4675-4678.
12. Lecomte T, Berger A, Zinzindohoueé F et al. Detection of free-circulating tumorassociated DNA in plasma of colorectal cancer patients and its association with prognosis. Int J Cancer 2002; 100: 542-548.
13. Gautschi O, Bigosch C, Huegli B et al. Circulating deoxyribonucleic acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy. J Clin Oncol 2004; 22: 4157-4164.
14. Bastian PJ, Palapattu GS, Yegnasubramanian S et al. Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy. Clin Cancer Res 2007; 13: 5361-5367.
15. Lo YM, Tein MS, Lau TK et al. Quantitative analysis of fetal DNA in maternal plasma and serum: Implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998; 62: 768-775.
16. Pfreundschuh M, Schubert J, Ziepert M et al. German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL). Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: A randomised controlled trial (RICOVER-60). Lancet Oncol 2008; 9: 105-116.
17. Soraé F, Piccirillo N, Chiusolo P et al. Mitoxantrone, carboplatin, cytosine arabinoside, and methylprednisolone followed by autologous peripheral blood stem cell transplantation: A salvage regimen for patients with refractory or recurrent non-Hodgkin lymphoma. Cancer 2006; 106: 859-866.
18. Diehl V, Franklin J, Pfreundschuh M et al. German Hodgkin's Lymphoma Study Group. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease. N Engl J Med 2003; 348: 2386-2395.
19. Jung M, Klotzek S, Lewandowski M et al. Changes in concentration of DNA in serum and plasma during storage of blood samples. Clin Chem 2003; 49: 1028-1029.
20. MacLennan KA, Bennett MH, Tu A et al. Relationship of histopathologic features to survival and relapse in nodular sclerosing Hodgkin's disease. A study of 1659 patients. Cancer 1989; 64: 1686-1693.
21. Diehl F, Li M, Dressman D et al. Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci U S A 2005; 102: 16368-16373.
22. Rago C, Huso DL, Diehl F et al. Serial assessment of human tumor burdens in mice by the analysis of circulating DNA. Cancer Res 2007; 67: 9364-9370.
23. Choi JJ, Reich CF III, Pisetsky DS. The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells. Immunology 2005; 15: 55-62.
24. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993; 329: 987-994.
25. Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med 1998; 339: 1506-1514.